View in EDS HTML Full Text PDF Full Text

Patient-guided dose reduction of tyrosine kinase inhibitors in chronic myeloid leukaemia (RODEO study): study protocol for a prospective, multicentre, single-arm trial.

Saved in:
Bibliographic Details
Title: Patient-guided dose reduction of tyrosine kinase inhibitors in chronic myeloid leukaemia (RODEO study): study protocol for a prospective, multicentre, single-arm trial.
Authors: Djodikromo MF; Department of Haematology, Radboud university medical center, Nijmegen, The Netherlands., Hermens RP; Scientific Institute for Quality of Healthcare (IQ healthcare), Radboud university medical center Nijmegen, Nijmegen, The Netherlands., Bemt BJVD; Department of Pharmacy, Sint Maartenskliniek, Nijmegen, The Netherlands., Smit Y; Department of Haematology, Radboud university medical center, Nijmegen, The Netherlands., Govers TM; Department of medical imaging, Radboud university medical center, Nijmegen, The Netherlands., Bekker CL; Department of Pharmacy, Radboud university medical center, Nijmegen, The Netherlands. charlotte.bekker@radboudumc.nl., Blijlevens NM; Department of Haematology, Radboud university medical center, Nijmegen, The Netherlands.
Source: BMC cancer [BMC Cancer] 2023 Mar 10; Vol. 23 (1), pp. 231. Date of Electronic Publication: 2023 Mar 10.
Publication Type: Journal Article
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36899295
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Patient-guided dose reduction of tyrosine kinase inhibitors in chronic myeloid leukaemia (RODEO study): study protocol for a prospective, multicentre, single-arm trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Djodikromo+MF%22">Djodikromo MF</searchLink>; Department of Haematology, Radboud university medical center, Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Hermens+RP%22">Hermens RP</searchLink>; Scientific Institute for Quality of Healthcare (IQ healthcare), Radboud university medical center Nijmegen, Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Bemt+BJVD%22">Bemt BJVD</searchLink>; Department of Pharmacy, Sint Maartenskliniek, Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Smit+Y%22">Smit Y</searchLink>; Department of Haematology, Radboud university medical center, Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Govers+TM%22">Govers TM</searchLink>; Department of medical imaging, Radboud university medical center, Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Bekker+CL%22">Bekker CL</searchLink>; Department of Pharmacy, Radboud university medical center, Nijmegen, The Netherlands. charlotte.bekker@radboudumc.nl.<br /><searchLink fieldCode="AU" term="%22Blijlevens+NM%22">Blijlevens NM</searchLink>; Department of Haematology, Radboud university medical center, Nijmegen, The Netherlands.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100967800%22">BMC cancer</searchLink> [BMC Cancer] 2023 Mar 10; Vol. 23 (1), pp. 231. <i>Date of Electronic Publication: </i>2023 Mar 10.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100967800 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1471-2407 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214712407%22">14712407 </searchLink><i>NLM ISO Abbreviation: </i>BMC Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36899295
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s12885-023-10697-6
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 231
    Titles:
      – TitleFull: Patient-guided dose reduction of tyrosine kinase inhibitors in chronic myeloid leukaemia (RODEO study): study protocol for a prospective, multicentre, single-arm trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Djodikromo MF
      – PersonEntity:
          Name:
            NameFull: Hermens RP
      – PersonEntity:
          Name:
            NameFull: Bemt BJVD
      – PersonEntity:
          Name:
            NameFull: Smit Y
      – PersonEntity:
          Name:
            NameFull: Govers TM
      – PersonEntity:
          Name:
            NameFull: Bekker CL
      – PersonEntity:
          Name:
            NameFull: Blijlevens NM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 10
              M: 03
              Text: 2023 Mar 10
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1471-2407
          Numbering:
            – Type: volume
              Value: 23
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: BMC cancer
              Type: main
ResultId 1